BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14697644)

  • 1. Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia.
    Lloveras E; Granada I; Zamora L; Espinet B; Florensa L; Besses C; Xandri M; Pérez-Vila ME; Millà F; Woessner S; Solé F
    Cancer Genet Cytogenet; 2004 Jan; 148(1):71-6. PubMed ID: 14697644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
    Stella F; Pedrazzini E; Rodríguez A; Baialardo E; Kusminsky G; Arbelbide J; Fantl DB; Slavutsky I
    Cytogenet Genome Res; 2011; 134(4):249-59. PubMed ID: 21734361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar cytogenetic abnormalities in two cases of plasma cell leukemia.
    Smadja N; Krulik M; Louvet C; de Gramont A; Gonzalez-Canali G; Mougeot-Martin M
    Cancer Genet Cytogenet; 1991 Mar; 52(1):123-9. PubMed ID: 2009507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique.
    Avet-Loiseau H; Daviet A; Brigaudeau C; Callet-Bauchu E; Terré C; Lafage-Pochitaloff M; Désangles F; Ramond S; Talmant P; Bataille R
    Blood; 2001 Feb; 97(3):822-5. PubMed ID: 11157506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Implications of Monosomies in Patients With Multiple Myeloma.
    Shin SY; Eom HS; Sohn JY; Lee H; Park B; Joo J; Jang JH; Lee MN; Kim JK; Kong SY
    Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):159-164.e2. PubMed ID: 28089441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H; Li JY; Morineau N; Facon T; Brigaudeau C; Harousseau JL; Grosbois B; Bataille R
    Blood; 1999 Oct; 94(8):2583-9. PubMed ID: 10515861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma with monosomy 13 developed in trisomy 13 acute myelocytic leukemia: numerical chromosome abnormality during chromosomal segregation process.
    Sashida G; Ito Y; Nakajima A; Kawakubo K; Kuriyama Y; Yagasaki F; Bessho M; Ohyashiki K
    Cancer Genet Cytogenet; 2003 Mar; 141(2):154-6. PubMed ID: 12606134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance.
    Lloveras E; Solé F; Florensa L; Besses C; Espinet B; Gil M; Pérez-Vila ME; Pedro C; Abella E; Sans-Sabrafen J; Woessner S
    Cancer Genet Cytogenet; 2002 Jan; 132(1):25-9. PubMed ID: 11801304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13.
    Avet-Louseau H; Daviet A; Sauner S; Bataille R;
    Br J Haematol; 2000 Dec; 111(4):1116-7. PubMed ID: 11227093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients.
    Gutensohn K; Weh HJ; Walter TA; Hossfeld DK
    Ann Hematol; 1992 Aug; 65(2):88-90. PubMed ID: 1511063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and fluorescence in situ hybridization studies in four cases of plasma cell leukemia.
    Lloveras E; Solé F; Espinet B; Besses C; Asensio A; Abella E; Woessner S; Florensa L
    Cancer Genet Cytogenet; 2000 Sep; 121(2):163-6. PubMed ID: 11063801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cell leukemia with an unusual karyotype and prolonged survival following oral alkylating agent therapy.
    Wiernik PH; Sciortino D; Paietta E; Papenhausen P; Ciobanu N; Roberts M
    J Cancer Res Clin Oncol; 1987; 113(5):495-7. PubMed ID: 3624303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?
    Jimenez-Zepeda VH; Neme-Yunes Y; Braggio E
    Eur J Haematol; 2011 Jul; 87(1):20-7. PubMed ID: 21692850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
    Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
    Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
    Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
    Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-random chromosomal aberrations associated with multiple myeloma.
    Lewis JP; MacKenzie MR
    Hematol Oncol; 1984; 2(4):307-17. PubMed ID: 6335483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization.
    Chang H; Bouman D; Boerkoel CF; Stewart AK; Squire JA
    Leukemia; 1999 Jan; 13(1):105-9. PubMed ID: 10049044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic analysis and fluorescence in situ hybridization in a case of IgD multiple myeloma.
    Weinländer G; Drach J; Raderer M; Okamoto I; Ackermann J; Stögermayer B; Fazeny B; Nowotny H; Marosi C
    Cancer Genet Cytogenet; 1998 Sep; 105(2):172-6. PubMed ID: 9723037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.